跳至主要内容
临床试验/NCT04620577
NCT04620577Unknown不适用

The Influence of Antibiotics on the Incidence of Biliary Tract Infections After PTCD for Malignant Obstructive Jaundice

Xian-Jun Yu1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2020年10月20日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
120
试验地点
1
主要终点
Incidence of patients with biliary tract infection after surgery

研究概览

简要总结

To investigate the influence of antibiotics on the incidence of biliary tract infections after PTCD for malignant obstructive jaundice.

详细描述

This project designed a large-scale, single-center, prospective randomized controlled clinical trial to explore the impact of antibiotics on the incidence of biliary tract infections after PTCD with malignant obstructive jaundice. This study will provide evidence-based medical evidence for the need for routine use of antibiotics to prevent biliary tract infections after PTCD with malignant obstructive jaundice, and provide references for clinicians to prevent patients from PTCD infections.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-80 years old;
  • ECOG score 0-1 before operation;
  • Patients diagnosed as pancreatic head cancer and periampullary cancer according to preoperative imaging, including ampullary cancer, extrahepatic bile duct cancer and duodenal papillary cancer;
  • Bilirubin>200 mmol/L before PTCD , and the duration of PTCD continuous drainage >2 weeks;
  • Volunteer to participate and sign the informed consent form;

排除标准

  • Decompensated liver cirrhosis, acute and chronic hepatitis and other diseases before surgery;
  • A history of other malignant tumors before surgery;
  • Duration of preoperative PTCD drainage<2 weeks;
  • Jaundice caused by other reasons besides cancer around the ampulla and cancer of the head of the pancreas;

结局指标

主要结局

Incidence of patients with biliary tract infection after surgery

时间窗: October 2020 to June 2023

Incidence of patients with biliary tract infection after surgery

次要结局

  • Decline rate of bilirubin in patients after PTCD(October 2020 to June 2023)

研究者

发起方
Xian-Jun Yu
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Xian-Jun Yu

President of Shanghai Pancreatic Cancer Institute

Fudan University

研究点 (1)

Loading locations...

相似试验